Director
Don Benson, MD, PhD
Interim Director, Division of Hematology
Dr. Benson is an oncologist and hematologist caring for patients with multiple myeloma, amyloidosis and other blood cancers. He is also actively involved in clinical and laboratory-based research to develop new treatments and approaches to these conditions.
Clinicians
Lapo Alinari, MD, PhD
Dr. Alinari is a board certified hematologist with a clinical and research focus on lymphoid malignancies. My clinical expertise includes indolent and aggressive B-cell Non-Hodgkin lymphomas as well as Hodgkin disease
Sabarish Ayyappan, MBBS
Dr. Ayyappan specializes in B-cell non-Hodgkin lymphoma, Hodgkin lymphoma and lymphoma in the elderly.
Robert Baiocchi, MD, PhD
Dr. Baiocchi is an oncologist treating patients with blood cancers. His clinical expertise includes hematology, AIDS-related lymphomas and non-Hodgkin lymphoma.
Gregory Behbehani, MD, PhD
Dr. Behbehani is a hematologist-oncologist and provides clinical, inpatient care of patients with acute myeloid leukemia and acute lymphocytic leukemia.
Seema Bhat, MD
Dr. Bhat is a hematologist who specializes in treating patients with chronic lymphocytic leukemia (CLL).
Bhavana Bhatnagar, DO
Dr. Bhatnagar is a hematologist specializing in acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, myelodysplastic syndromes and other blood cancers.
James Blachly, MD
Dr. Blachly is an oncologist focused on the treatment of patients diagnosed with hairy cell, acute myeloid, acute lymphocytic and chronic lymphocytic leukemia.
Jonathan Brammer, MD
Dr. Brammer is a hematologist specializing in patients with T-cell lymphoma, T-cell leukemia, non-Hodgkin lymphoma and allogenic and autologous stem cell transplantation.
Naresh Bumma, MD
Dr. Bumma is a hematologist specializing in the diagnosis and treatment of plasma cell disorders such as multiple myeloma and amyloidosis.
John Byrd, MD
Dr. Byrd is a board certified hematologist and his area of focus is caring for patients with chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).
Camila Masias Castanon, MD
Dr. Castanon is a hematologist and instructor in the Division of Hematology.
Spero Cataland, MD
Dr. Cataland is a hematologist with a focus on non-malignant blood disorders. His specific areas of expertise include platelet abnormalities, blood clotting and bleeding disorders.
Maria Chaudhry, MD
Dr. Chaudhry is an assistant professor and cares for patients with plasma cell dyscrasias and other blood cancers.
Hannah Choe, MD
Dr. Choe is a hematologist who specializes in acute myeloid leukemia, myeloproliferative diseases and other conditions requiring allogeneic stem cell transplantation.
Beth Christian, MD
Dr. Christian is a hematologist and oncologist who specializes in treating patients with Hodgkin and non-Hodgkin lymphoma.
Payal Desai, MD
Dr. Desai is a hematologist whose area of expertise is treating patients with sickle cell disease. She also serves as an associate professor of Internal Medicine.
Srinivas Devarakonda, MD
Dr. Devarakonda is a hematologist and instructor in the Division of Hematology.
Yvonne Efebera, MD
Dr. Efebera's clinical focus at the OSUCCC – James is B-cell lymphoid malignancies, including multiple myeloma, amyloidosis, Waldenstrom's disease and stem cell and bone marrow transplant.
Naren Epperla, MD
Dr. Epperla is a hematologist specializing in treating non-Hodgkin lymphoma, Hodgkin lymphoma and other blood cancers. He also serves as an assistant professor in Internal Medicine.
Ramiro Garzon, MD
Dr. Garzon is an oncologist treating patients with leukemia and other blood cancers. His specific areas of focus include adult T cell leukemia-lymphoma, bone marrow transplantation and chronic B-cell lymphocytic leukemia.
Michael Grever, MD
Dr. Grever is an oncologist who treats patients with leukemia and other blood cancers.
Tamanna Haque, MD
Dr. Haque is a hematologist/oncologist who specializes in treating leukemia with a focus on the treatment of myelodysplastic syndrome.
Samantha Jaglowski, MD
Dr. Jaglowski is a hematologist specializing in stem cell transplants for patients battling lymphoma and chronic lympocytic leukemia.
Crystal Kelly, MD
Dr. Kelly is an assistant professor of Internal Medicine with clinical Interests in the diagnostic evaluation of hematologic and oncologic malignancies.
Abdullah Khan, MBBS
Dr. Khan is a hematologist specializing in multiple myeloma and related plasma cell disorders.
Eric Kraut, MD
As a hematologist, Dr. Kraut focuses on treating bleeding and clotting disorders, sickle cell anemia, myeloproliferative disease, hairy cell leukemia and multiple myeloma. I’m a professor of Internal Medicine and serve as director of benign hematology.
Karilyn Larkin, MD
I’m a hematologist with specialties in acute myeloid leukemia (AML) and blood and marrow transplant (BMT). I also serve as a clinical instructor at The Ohio State University.
Meixiao Long, MD, PhD
As a hematologist-oncologist, Dr. Long has a special interest in treating patients with chronic lymphocytic leukemia (CLL). His research focus has been on developing novel therapeutics that will boost the patient’s immune system to naturally fight the disease. Presently, I’m clinical instructor in hematology-oncology.
Kami Maddocks, MD
Dr. Maddocks is an associate professor of clinical internal medicine in the Division of Hematology. Her job includes working as a hematologist specializing in treating patients with B-cell malignancies, including non-Hodgkin lymphoma, Hodgkin lymphoma and chronic lymphocytic leukemia.
Alice Mims, MD
Dr. Mims is a medical oncologist with a special focus in treating patients suffering from acute and chronic myeloid diseases, focusing particularly on acute myeloid leukemia (AML). She also serves as an assistant professor of Hematology.
Luay Mousa, MD
Dr. Mousa is an assistant professor of Internal Medicine. His clinical interests include lymphomas, myeloma, and new cancer diagnosis and management.
Sam Penza, MD
Dr. Penza is a senior transplant physician with more than 20 years experience in blood and marrow/hematopoietic stem cell transplantation (BMT/HSCT). Additionally, he serves as medical director of quality at The James and physician advisor for Ohio State.
Kerry Rogers, MD
Dr. Rogers is a hematologist and oncologist dedicated to advancing the care and treatment of patients with chronic lymphocytic leukemia and autoimmune cytopenias. She also serves as an assistant professor.
Ashley Rosko, MD
Dr. Rosko is an oncologist treating patients with blood cancers. Her areas of expertise include hematology, geriatric oncology and multiple myeloma. She serves as an associate professor and is the director of the Blood Cancer and Aging Program.
Ayman Saad, MB/BCH
Dr. Saad is a hematologist who specializes in treating patients with blood cancers, specifically leukemia and myelodysplastic syndromes.
Sumi Vasu, MBBS
Dr. Vasu is an oncologist treating patients with leukemia. She specializes in hematology with a specific focus on acute myeloid leukemias, myelodysplastic syndromes and bone marrow transplantation. She serves as an assistant professor in the Division of Hematology.
Alison Walker, MD
Dr. Walker is an oncologist treating patients with leukemia and other blood cancers. Her specific areas of focus include acute myeloid leukemias (AML) and myelodysplastic syndromes. I serve as an associate professor in the Division of Hematology and director of the Hematology and Medical Oncology Fellowship Program.
Katherine Walsh, MD
Dr. Walsh is an associate professor of Clinical Internal Medicine. Her clinical interest is in cytopenia.
Tzu-Fei Wang, MD
Dr. Wang is an assistant professor of Internal Medicine. Her research interests are emostasis and thrombosis, including venous thromboembolism, bleeding disorders, von Willebrand disease, hemophilia and benign hematolgy.
Basem William, MD
Dr. William is an assistant professor and hematologist with interest, and expertise, in treating lymphoma especially cutaneous lymphomas. He also leads the multidisciplinary cutaneous lymphoma program.
Jennifer Woyach, MD
Dr. Woyach is an oncologist treating patients with blood cancers. She specializes in chronic lymphocytic leukemia (CLL) and B-cell lymphomas. She also serves as an associate professor in the Division of Hematology.
Researchers
Clara Bloomfield, MD
Dr. Bloomfield is a distinguished university professor & William G. Pace III Professor of Cancer Research.
Jonathan Butchar, PhD
Dr. Butchar is a research assistant professor in the Division of Hematology. His work involves bringing pathogenesis and tumor immunotherapy together by studying the interactions between Fc-gamma receptor and Toll-like receptor signaling.
Adrienne Dorrance, PhD
Dr. Dorrance is an instructor in the Division of Hematology. Her research centers on identifying pathways important for the regulation of normal and leukemic stem-cell functions.
Erin Hertlein, PhD
Dr. Hertlein is a research assistant professor and her research focuses on acute myeloid leukemia and diffuse large B-cell lymphoma.
Rosa Lapalombella, PhD
Dr. Lapalombella is an associate professor of Internal Medicine. Her research interests are experimental Therapeutics in B-Cell malignancies and benign hematology.
David Lucas, PhD
Dr. Lucas is a research assistant professor of Internal Medicine. His research interests include Pharmacology of novel anti-leukemic agents, role of transcriptional and translational regulation in tumor cell survival and drug resistance.
Bethany Mundy-Bosse, PhD
Dr. Mundy-Bosse's research is focused on defining the mechanisms driving innate immune cell defects in cancer patients, primarily hematologic malignancies.
Raj Muthusamy, DVM, PhD
Dr. Muthusamy is a professor of Internal Medicine. His research interests include biological therapeutics in B cell malignancies, signaling and lymphocyte development, animal models of lymphoid malignancies, and mircoRNA and targeted delivery.
Chris Oakes, PhD
Dr. Oakes is an assistant professor of Internal Medicine. His current research focuses on investigating the role of epigenetics in hematological malignancies, with a primary focus on understanding the evolution and impact of epigenetic programming on the cancer cell phenotype.
Lynn O'Donnell, PhD
Dr. O'Donnell is an associate professor of Internal Medicine. Her research interests novel cellular therapies for malignancies and regenerative medicine, translational development, GMP manufacturing, IND and IDE submissions for FDA
Parvathi Ranganathan, PhD
Dr. Ranganathan is a research assistant professor. Her research interests include immunobiology of aGVHD, non-coding RNAs in aGVHD, experimental therapeutics in aGVHD
Deepa Sampath, PhD
Dr. Sampath is an assistant professor of Internal Medicine. She is a member of the Leukemia Research Program at OSUCCC – James, where her research focuses on the epigenetics of lymphoid malignancies.
Lalit Sehgal, MPhil, PhD
Dr. Sehgal is an assistant professor of Internal Medicine. He is a member of the Leukemia Research Program at OSUCCC – James, where his research focuses on the role of tumor microenvironment in the progression of B-cell lymphomas.
Susheela Tridandapani, PhD
Dr. Tridandapani's research examines the molecular mechanisms of innate immune responses to bacterial pathogens and IgG-immune complexes, particularly in the context of monoclonal antibody therapy for cancer.
Pearlly Yan, MD
Dr. Yan is a research assistant professor. Her research uses sequencing approach to interrogate cancer and disease-related methylomes, developing novel sequencing library protocols and custom computation pipeline to capture the methylome at high resolution.
